The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
Tracking surgical supplies is a challenge. Average returns for picked supplies is low, O.R. in-and-out traffic to retrieve items is high, and…
On-Demand Educational Webinars
Outsourcing of hospital functions is a common and growing practice in the U.S. and comprises on average 25% of total non-labor spend in hospitals.…
Webcast
In this 3-part series, learn how the revenue cycle can impact your supply chain when embarking on a new software implementation or integration.
On-Demand Educational Webinars
We all question whether some health care supply chains outperform others, which competencies separate those supply chain professionals from t
On-Demand Educational Webinars
In this webinar, we discuss the clinical contract evaluation process, including government requirements, expectations, and improving contract…
On-Demand Educational Webinars
The perioperative services administration at Massachusetts General created a rigorous and rapid approach to raising the level of cost awareness among…